Developing, procuring, and distributing vaccines for COVID-19 could have very good or bad outcomes for solidarity, public health, and science. The European Union (EU), whose public health role advanced greatly in 2020, has a Vaccines Strategy that goes far beyond earlier EU procurement strategies.
The World Health Organization’s COVAX partnership pursues a global strategy of vaccines procurement and distribution. Governments are maximising their chances of access to vaccines for their own citizens with various combinations of national deals and international collaboration.
There are powerful reasons to expect national egotism. The question is when the chosen case for collaboration makes solidarity the rational approach. Full article here